|Articles|April 12, 2022
- Applied Clinical Trials-04-01-2022
- Volume 31
- Issue 4
Applied Clinical Trials April 2022 Issue (PDF)
Click the title above for a link to open the Applied Clinical Trials April 2022 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 3 years ago
Addressing the Cost Barrier to Inclusive Clinical Trialsover 3 years ago
DCT Risk/Benefit Profile: A Focus on Adherenceover 3 years ago
Program Aims to Tap Africa's Potential in Pharmacometricsover 3 years ago
DCTs’ Broader and Multifaceted Implicationsover 3 years ago
FDA, Congress Re-Examine Accelerated Approval ProgramNewsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
AstraZeneca’s Phase III POTOMAC Trial Shows Imfinzi Significantly Improves Disease-Free Survival in High-Risk NMIBC
2
Honing the Power of AI for Next Generation Trial Oversight and Execution
3
The Value of Pragmatic Randomized Clinical Trials: Strategic Approaches for Real-World Impact
4
Verzenio and Kisqali Deliver Positive Long-Term Results in Early Breast Cancer Trials
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
